Skip to main content
. 2023 Feb 3;7(13):3117–3127. doi: 10.1182/bloodadvances.2022009411

Figure 3.

Figure 3.

Patients who were transfusion dependent at baseline and achieved TI for ≥56 days. Other responders are patients with CRi, PR, or MLFS. Nonresponders are patients in response assessment categories other than CR/CRh, CRi, PR, and MLFS.